Ghana

Sanofi-aventis, one of the major actors in the fight against epilepsy in the developed world, is also committed to the treatment of epilepsy worldwide using its two major treatments, Gardenal and, more importantly, Depakine / valproate Winthrop within a tiered pricing policy. In Mali, sanofi-aventis is working with Sant Sud and the Association des Medecins de Campagne (AMC) which have created the Reseau Action Recherche contre l'Epilepsie (RARE).

The Pfizer Global Health Fellows program utilizes the professional expertise of Pfizer employees through specialized volunteer assignments with nonprofit organizations to improve health care services for underserved communities around the world. Since 2003, more than 230 employees with a range of technical skills have served in 39 nations for 3-6 month assignments investing nearly 200,000 hours of skills-based service to help increase the capacity of nonprofits organizations providing health care to the underserved (in the reporting period, 54 Global Health Fellows were deployed).

Unveiled at the Clinton Global Initiative in 2006, Mobilize Against Malaria is Pfizer's signature social investment in malaria, supporting programs to reduce the malaria burden in three hard-hit African countries, Ghana, Kenya and Senegal, over a five year period (2007-2011). Under this USD 15 million program, Pfizer helps four leading NGOs to close critical gaps in malaria treatment, training, and public demand for quality services. In Ghana, Pfizer is helping to bring the public and private sectors together to find new solutions to the malaria challenge.

MVI works to link government, industry, and academia partners with field trial sites in malaria endemic countries as early as feasible in the development process.